Skip to main content
Y

YungShin Global Holding Corporation — Investor Relations & Filings

Ticker · 3705 TW Financial and insurance activities
Filings indexed 2,125 across all filing types
Latest filing 2026-03-31 Audit Report / Informat…
Country TW Taiwan
Listing TW 3705

About YungShin Global Holding Corporation

https://www.yungshingroup.com

YungShin Global Holding Corporation is an investment holding company focused on the pharmaceutical and comprehensive healthcare sectors. Through its subsidiaries, the group manages an integrated value chain that spans research and development, manufacturing, and global distribution. Its diverse product portfolio includes human prescription and over-the-counter generic medicines, active pharmaceutical ingredients (APIs), animal health products, and health supplements. The company also provides cosmetics and specialty chemicals. Leveraging advanced enterprise resource planning systems to ensure operational transparency and quality control, the group serves a broad international market. Its core mission centers on delivering holistic health solutions and maintaining a robust presence across the healthcare supply chain, supported by a long-standing commitment to social welfare and community health initiatives.

Recent filings

Filing Released Lang Actions
114年第4季財務報告書 — 202504_3705_AI3.pdf
Audit Report / Information Classification · 1% confidence The document contains the company’s individual audited financial statements and the external auditor’s report (會計師查核報告書) prepared by KPMG, including the balance sheet, income statement, cash flow statement, and extensive notes. It does not include broader narrative sections typical of a full annual report (e.g., management discussion & analysis, corporate overview), but is a standalone audit report with applied accounting principles and audit opinions. Therefore, it matches the Audit Report / Information category. FY 2025
2026-03-31 Chinese
114年第4季財務報告書 — 202504_3705_AI1.pdf
Audit Report / Information Classification · 1% confidence The document is titled “合併財務報告暨會計師查核報告” and includes the full auditor’s report from KPMG along with detailed consolidated financial statements and notes. It is not a brief announcement or investor presentation, nor does it include narrative management discussion or other Annual Report content. It is a standalone audited financial report, fitting the definition for Audit Report / Information (Code: AR). FY 2025
2026-03-31 Chinese
114年第4季財務報告書 — 202503_3705_AIA.pdf
Regulatory Filings
2026-03-31 Chinese
114年第4季財務報告書 — 202503_3705_AI1.pdf
Regulatory Filings
2026-03-31 Chinese
114年第4季財務報告書 — 202502_3705_AIA.pdf
Regulatory Filings
2026-03-31 Chinese
114年第4季財務報告書 — 202502_3705_AI1.pdf
Regulatory Filings
2026-03-31 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.